Skip to Content

Johnson and Johnson vaccine could cause Guillain-Barré Syndrome

Remaining Ad Time Ad - 00:00
Johnson and Johnson vaccine

(WSIL)--The FDA has added a warning to the Johnson and Johnson COVID-19 vaccine, for a potential risk of a rare neurological complication known as Guillain-Barré Syndrome (GBS).

GBS is a rare disorder where the immune system attacks the nerves, causing a paralysis that could potentially spread across the entire body if not treated.

The good news is that doctors say the disorder has a cure rate of almost 100%.

GBS is easily treated, and typically 1 to 3 out of every 100,000 people develop the disorder.

According to Dr. Jeff Ripperda, the risk of developing the disorder is much lower than dying of COVID.

"The immune response kicking up and causing some side effects is a well known occurrence. But again, at the same time, when you get down to it, for any one individual when they say 'what are the odds of me dying of covid versus what are the odds of me having a significant side effect of the vaccine?' You're more likely to die of COVID than you are to have a major side effect from the vaccine," said Dr. Ripperda.

According to Dr. Ripperda, the chances of developing GBS from the vaccine are 1 in 120,000.

About 1 out of every 500 people who've gotten COVID since the start of the pandemic have died.

Now the Johnson and Johnson vaccine isn't the only thing that can cause Guillain-Barré Syndrome.

There have been reports of people developing GBS from having the stomach flu, mono, influenza, or even the common cold.

WSIL logo

Madeline Parker

Madeline Parker is a Multimedia Journalist at News 3 WSIL. Madeline joined the team in 2020 and graduated from Southern Illinois University Carbondale with a Bachelor’s in Electronic Journalism and a minor in Communication Studies.

Skip to content